Network Point-Of-Care Glucose Testing Market Expected to Reach US ~$1.79 Billion and CAGR 4.0% by 2029 – Polaris Market Research

Actigraphy Sensors And Psg Devices Market

The global Network Point-of-Care Glucose Testing Market size is expected to reach USD 1.79 billion by 2029 according to a new study by Polaris Market Research.

The significant factors of the market, such as growing demand for data-based patient analysis, remote patient monitoring, and incorporation of advanced data transfer techniques, attribute to the market growth. In addition, increasing incidences of diabetes and other lifestyle-related diseases further foster the demand for network point-of-care testing.

Request Sample Copy of Research Report @         

(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)

The rising demand for technologically developed network point-of-care glucose testing devices is creating lucrative growth opportunities. Thus, for this, various industry players are working on advancements and innovations in the devices. The incorporation of developed technologies such as Infrared and BLE and the existing restructuring of the products by several competitors are expected to drive the new product development and launches in the industry.

Innovative advancements like optical devices and instruments have facilitated the significant information used for medical treatments. For instance, in January 2018, Roche introduced its new product, “Accu-check,” which enables a blood glucose monitoring system that presents a unique shred with a large easy-edge dosing region. Hence, in turn, these factors may accelerate growth for network point-of-care testing over the coming years.

Buy a Premium Report –

Industry participants such as F. Hoffmann-La Roche Ltd., Bayer AG/Ascensia Diabetes Care Holdings AG, Nova Biomedical, Abbott, LLC (Lifescan, Inc.), and Danaher are key players operating in the industry. There are abundant competitors in the industry introducing and advancing their products for expanding their business operations around the world. For instance, in June 2021, Roche’s Accu-Chek Inform II Hospital Blood Glucose System was officially approved in Canada. ACI II helps the PoC physicians, coordinators, IT experts, and nurses.

Inquire more about this report before purchase @         

(You may enquire about a reported quote OR available discount offers to our sales team before purchase.)

Polaris Market Research has segmented the network point-of-care glucose testing market report on the basis of product and region:

Network Point-of-Care Glucose Testing, Product Outlook (Revenue – USD Million, 2017 – 2029)

  • i-STAT
  • Accu-Chek Inform II
  • StatStrip
  • HemoCue
  • CareSens Expert Plus
  • BAROzen H Expert Plus

Browse detailed report with in-depth TOC – Network Point-of-Care Glucose Testing Market

About Us:
Polaris Market Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Polaris Market Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We at Polaris are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defense, among different ventures, present globally.

Contact Us:

Polaris Market Research

Phone: +1-929-297-9727